News

Current Recommendations of the Expert Panel on the Management of von Willebrand Disease
Von Willebrand disease (vWD) is a common congenital bleeding disorder. The care of patients with vWD involves significant variability due to bleeding manifestations and treatment options. The new recommendations from 2021 regarding the care of people with vWD are evidence-based and supported by the American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), the National Hemophilia Foundation USA (NHF), and the World Federation of Hemophilia (WFH). We bring you a concise summary of the key points.

How and with What the National Registry of Primary Immunodeficiencies Benefits Specialists and Patients

Update of the Blue Book: What's New in the Treatment of Metastatic NSCLC with an ALK Gene Mutation?

Brain Metastases Are Not an Absolute Contraindication for Antiplatelet Therapy

Complete remission of ALK-positive lung cancer in a patient after multiple lines of targeted therapy – a case study

How Do Vaccinated MS Patients Fare with COVID-19 Antibodies?

When Teriflunomide and Interferon Join Forces

Fixed Combination of Tiotropium/Olodaterol in SMI Inhaler and Its Benefits in COPD Treatment

Protection of Ovarian Function During Breast Cancer Treatment

New Antidiabetic Drugs in Cardiovascular Prevention in International Recommendations
Conferences
News from the world of medicine
All conferences
Popular this week
- How Do Chronic and Acute Stress Affect the Gastrointestinal Tract?
- Does AI Evaluate Patients' Health More Accurately Than Doctors?
- FDA Warns Against Self-Monitoring Glucose Using Smartwatches. What About in Czechia?
- How to Align Heart and Mind: The Brain of Lovers in Action
- Brain scans of patients with multiple sclerosis will be evaluated by AI